Preclinical Therapeutic Evaluation of ALY101 in a murine model of neurofibromatosis type 2

syn27261829

Created By review-service

grantDOI: https://doi.org/10.48105/pc.gr.151540
studyName: Preclinical Therapeutic Evaluation of ALY101 in a murine model of neurofibromatosis type 2
dataStatus: Data Pending
initiative: Drug Discovery Initiative Registered Reports
studyLeads: D. Wade Clapp
studyStatus: Active
diseaseFocus: Neurofibromatosis type 2
institutions: Indiana University
fundingAgency: CTF
manifestation: Schwannoma
relatedStudies: syn27261816 syn26383473 syn26238842 syn35632706
studyFileviewId: syn27261834
syn27261831
syn27261832
syn27261834
syn27261833

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Preclinical Therapeutic Evaluation of ALY101 in a murine model of neurofibromatosis type 2

syn27261829

Drop files to upload

Preclinical Therapeutic Evaluation of ALY101 in a murine model of neurofibromatosis type 2 page is loading…